1 asset in Scrotum Cancer
Therapeutic assets addressing Scrotum Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Eribulin Monomethanesulfonate Scrotum Cancer | OHSU Knight Cancer Institute | P1 | CC (43) |
Therapeutic assets addressing Scrotum Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Eribulin Monomethanesulfonate Scrotum Cancer | OHSU Knight Cancer Institute | P1 | CC (43) |